Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Betamethasone Valerate
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Alembic Pharma Gets USFDA Nod for Generic Drug
Details : Betamethasone valerate foam, generic version of Luxiq foam is a glucocorticoid receptor agonist which is indicated for the treatment of moderate to severe psoriasis of scalp.
Product Name : Luxiq-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 26, 2024
Lead Product(s) : Betamethasone Valerate
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable